Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
100%(3 trials)

Phase Distribution

Ph phase_4
2
40%
Ph not_applicable
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

withdrawn120%
active_not_recruiting120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Feasibility of Delivering VergeRx at FQHCs

NCT06161675
completedphase_2

Quit Smoking Study for People Who Use E-Cigarettes

NCT04946825
withdrawnphase_2

Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers

NCT01907594
completedphase_4

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

NCT01574703
completedphase_4

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

NCT01456936

Clinical Trials (5)

Showing 5 of 5 trials
NCT06161675Not Applicable

Feasibility of Delivering VergeRx at FQHCs

Active Not Recruiting
NCT04946825Phase 2

Quit Smoking Study for People Who Use E-Cigarettes

Completed
NCT01907594Phase 2

Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers

Withdrawn
NCT01574703Phase 4

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

Completed
NCT01456936Phase 4

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5